Death ligands induce apoptosis in tumour cells (Ashkenazi and Dixit, 1998; Papenfuss et al, 2008) independent of p53 and thus offer an alternative therapy to genotoxic agents (Ashkenazi, 2008). This evidence concerns the gene TP53 and neoplasm.